Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement ...
Measuring neurofilament light chain levels 48 hours after cardiac arrest can predict long-term cognitive impairment, ...
Routine early measurement of neurofilament light chain could help improve prediction of cognitive impairment after ...
Routine early measurement of the neurofilament light chain could help improve prediction of cognitive impairment after out-of ...
During intensive care after preterm births, babies can experience low oxygen in their tissue and cells—or hypoxia. Hypoxia is ...
Oryon Cell Therapies ("Oryon"), a clinical-stage biotechnology company focused on developing autologous neuron replacement ...
When Ron Cohen, M.D., CEO of Oryon Cell Therapies, recently dug into the company’s Parkinson’s disease data, he told Fierce ...
Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with ...
Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way ...
Scotland is now screening every newborn for a condition that can kill within two years. Here is what parents across the UK need to know.
Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to ...
International researchers develop NTAC, an AI that identifies neuronal types with 90% accuracy based purely on synaptic connectivity, outperforming traditional shape-based methods.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results